Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Current Taxes (2024 - 2026)

Axsome Therapeutics' Current Taxes history spans 3 years, with the latest figure at $99000.0 for Q1 2026.

  • On a quarterly basis, Current Taxes fell 89.69% to $99000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $99000.0, a 89.69% decrease, with the full-year FY2025 number at $101000.0, down 89.48% from a year prior.
  • Current Taxes hit $99000.0 in Q1 2026 for Axsome Therapeutics, down from $101000.0 in the prior quarter.
  • Over the last five years, Current Taxes for AXSM hit a ceiling of $960000.0 in Q4 2024 and a floor of $99000.0 in Q1 2026.
  • Historically, Current Taxes has averaged $514000.0 across 3 years, with a median of $493000.0 in 2024.
  • Biggest five-year swings in Current Taxes: skyrocketed 95.12% in 2025 and later plummeted 89.69% in 2026.
  • Tracing AXSM's Current Taxes over 3 years: stood at $960000.0 in 2024, then tumbled by 89.48% to $101000.0 in 2025, then decreased by 1.98% to $99000.0 in 2026.
  • Business Quant data shows Current Taxes for AXSM at $99000.0 in Q1 2026, $101000.0 in Q4 2025, and $960000.0 in Q1 2025.